Новости EN

News

  • Cause of Alzheimer's disease traced to mutation in common enzyme
    Researchers from Tokyo Metropolitan University have discovered a new mechanism by which clumps of tau protein are created in the brain, killing brain cells and causing Alzheimer's disease. A specific mutation to an enzyme called MARK4 changed the properties of tau, usually an important part of the skeletal structure of cells, making it more likely to aggregate and more insoluble. Getting to grips with mechanisms like this may lead to breakthrough treatments.
    More details
  • Scientists discover how a common mutation leads to 'night owl' sleep disorder
    A new study by researchers at UC Santa Cruz shows how a genetic mutation throws off the timing of the biological clock, causing a common sleep syndrome called delayed sleep phase disorder.
    More details
  • Plant genetic engineering to fight 'hidden hunger'
    More than two billion people worldwide suffer from micronutrient malnutrition due to deficiencies in minerals and vitamins. Poor people in developing countries are most affected, as their diets are typically dominated by starchy staple foods, which are inexpensive sources of calories but contain low amounts of micronutrients. In a new Perspective article, an international team of scientists, involving the University of Göttingen, explains how plant genetic engineering can help to sustainably address micronutrient malnutrition. The article was published in Nature Communications.
    More details
  • Cognitive disorders associated with risk for developing severe COVID-19
    Dementia and other cognitive disorders now appear to be risk factors for developing severe COVID-19, according to research from the University of Georgia. The findings highlight the need for special care for populations with these preexisting conditions during the pandemic.
    More details
  • Study examines the pharmacogenomics of opioid addiction
    In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general's office to research the pharmacogenomics of opioid addiction.
    More details
  • Study examines the pharmacogenomics of opioid addiction
    In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general's office to research the pharmacogenomics of opioid addiction.
    More details

SUBSCRIBE FOR OUR NEWS:

Sign up for our newsletter to stay updated on the news in the world of genetics
Your email
Thanks for subscribing!